Indapamide-d6

• UNSPSC Description:

  Indapamide-d6 is a deuterated labeled Indapamide[1]. Indapamide is an orally active sulphonamide diuretic agent, that can reduce blood pressure by decreasing vascular reactivity and peripheral vascular resistance. Indapamide is also can reduce left ventricular hypertrophy[2][5].

• Target Antigen:

  Isotope-Labeled Compounds; Potassium Channel

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Membrane Transporter/Ion Channel;Others

• Field of Research:

  Cardiovascular Disease

• Smiles:

  O=C(NN1C([2H])(C([2H])([2H])[2H])C([2H])([2H])C2=C1C=CC=C2)C3=CC=C(Cl)C(S(=O)(N)=O)=C3C

• Molecular Weight:

  385.90

• References & Citations:

  [1]Chaffman, M, et, al. Indapamide. Drugs 28, 189–235 (1984).|[2]Furman BL, et, al. A further examination of the possible effects of indapamide on glucose tolerance and insulin secretion in the rat and mouse. J Pharm Pharmacol. 1981 Nov;33(11):735-7.|[3]Lalande A, et, al. Indapamide, a thiazide-like diuretic, decreases bone resorption in vitro. J Bone Miner Res. 2001 Feb;16(2):361-70.|[4]Ma F, et, al. Indapamide lowers blood pressure by increasing production of epoxyeicosatrienoic acids in the kidney. Mol Pharmacol. 2013 Aug;84(2):286-95.|[5]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported